We are live on ! Find out more
PDM

Penn Davis McFarland Portfolio holdings

AUM $1.12B
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+32.35%
3 Year Est. Return
+86.8%
5 Year Est. Return
+114.42%
10 Year Est. Return
+392.43%
AUM
$343M
AUM Growth
-$21.2M
Cap. Flow
-$46M
Cap. Flow %
-13.4%
Top 10 Hldgs %
61.01%
Holding
45
New
2
Increased
1
Reduced
22
Closed
5

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$8.34M
2
BMY icon
Bristol-Myers Squibb
BMY
+$7.65M
3
GILD icon
Gilead Sciences
GILD
+$1.07M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$13.6M
2
EPD icon
Enterprise Products Partners
EPD
+$3.38M
3
AAPL icon
Apple
AAPL
+$3.33M
4
QCOM icon
Qualcomm
QCOM
+$2.63M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.52M

Sector Composition

Rank Sector Weight
1 Technology 29.23%
2 Energy 23.68%
3 Communication Services 15.24%
4 Healthcare 8.69%
5 Materials 7.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MTDR icon
26
Matador Resources
MTDR
$6.68B
$1.07M 0.31%
45,000
– –
APA icon
27
APA Corp
APA
$12.4B
$975K 0.28%
18,968
-940
-5% -$52.8K
DISH
28
DELISTED
DISH Network Corp.
DISH
$757K 0.22%
11,925
-300
-2% -$18.5K
XOM icon
29
ExxonMobil
XOM
$611B
$344K 0.1%
4,196
– –
AMZN icon
30
Amazon
AMZN
$2.66T
$275K 0.08%
6,200
– –
AMGN icon
31
Amgen
AMGN
$198B
$246K 0.07%
1,500
– –
CVX icon
32
Chevron
CVX
$373B
– –
-9,050
Closed -$1.06M
DOC icon
33
Healthpeak Properties
DOC
$15.5B
– –
-9,901
Closed -$294K
SKX
34
DELISTED
Skechers
SKX
– –
-78,223
Closed -$1.92M
TEVA icon
35
Teva Pharmaceuticals
TEVA
$37.3B
– –
-374,068
Closed -$13.6M
FIT
36
DELISTED
Fitbit, Inc. Class A common stock
FIT
– –
-122,929
Closed -$900K
1
2

Similar funds

EC
Estate Counselors Thiensville, Wisconsin $1.12B AUM 20.13% 1-Year Est. Return
JLBC
J.L. Bainbridge & Co Sarasota, Florida $1.12B AUM 25.58% 1-Year Est. Return
WA
Wealth Architects Mountain View, California $1.12B AUM 24.94% 1-Year Est. Return
FBFS
First Business Financial Services Madison, Wisconsin $1.12B AUM 22.16% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.12B AUM 32.75% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.12B AUM 21.35% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return

Penn Davis McFarland's Q1 2017 Portfolio in Review

As of Q1 2017, Penn Davis McFarland held 45 positions worth $343M, down 5.8% from $364M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Penn Davis McFarland withdrew a net $46M in Q1 2017, closing 5 positions and reducing 22 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $13.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Energy and Communication Services.

Against the trend, Penn Davis McFarland opened a new position in Celgene Corp worth $8.68M.

  • Penn Davis McFarland's largest Q1 2017 buy was Celgene Corp: 69,716 shares worth $8.68M.
  • Penn Davis McFarland added most to Gilead Sciences in Q1 2017, an estimated $1.07M increase.
  • Penn Davis McFarland's biggest Q1 2017 reduction was Enterprise Products Partners, cutting an estimated $3.38M.
  • Penn Davis McFarland fully exited Teva Pharmaceuticals in Q1 2017, selling an estimated $13.6M.
  • Penn Davis McFarland's ten largest holdings make up 61% of its $343M portfolio in Q1 2017.
  • Penn Davis McFarland opened 2 new positions and closed 5 in Q1 2017.
  • Penn Davis McFarland's portfolio value fell 5.8% quarter-over-quarter to $343M.

Based on Penn Davis McFarland's 13F filing for Q1 2017, filed 20 Apr 2017.